Navigation Links
Inverness Medical Innovations Announces Second Quarter 2008 Results
Date:7/29/2008

available to common stockholders

of $30.4 million. Potential dilutive shares consisting of 6,008,000 common

stock equivalent shares from the potential conversion of Series B

convertible preferred stock for the three months ended June 30, 2008 were

not used in the calculation of diluted net income per common share, on an

adjusted cash basis, because inclusion thereof would be antidilutive.

(k) Included in the weighted average diluted common shares for the

calculation of net income per common share for the three months ended June

30, 2007, on an adjusted cash basis, are dilutive shares consisting of

1,841,000 common stock equivalent shares from the potential exercise of

stock options and warrants. Potential dilutive shares consisting of

1,513,000 common stock equivalent shares from the potential conversion of

convertible debt securities for the three months ended June 30, 2007 were

not used in the calculation of diluted net income per common share, on an

adjusted cash basis, because inclusion thereof would be antidilutive.

Inverness Medical Innovations, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and

Reconciliation to Non-GAAP Adjusted Cash Basis Amounts

(in $000s, except per share amounts)

Six Months Ended June 30, 2008

Non-GAAP

Adjusted

Non-GAAP Cash

GAAP Adjustments Basis (a)

Net revenue $773,360 $- $773,360

Cost of revenue 386,868 (40,839)(b)(c)(d)(e) 346,029

Gross profit 386,492 40,839
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
2. Inverness - Chemogen Establish Exclusive License for TB Antibodies
3. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
4. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
7. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
10. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
11. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 AstraZeneca (NYSE: ... (UVa) in Charlottesville, today announced that they ... to enhance development of new treatments primarily ... secondary focus on peripheral vascular disease (PAD). ... The collaborative preclinical research projects will focus ...
(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 On ... the International Society for Medical Publication Professionals (ISMPP) ... Physicians in London, UK. More than 100 attendees ... new forum for publication professionals, editors, publishers, medical ... world of medical publications and the impact of ...
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... Lionbridge (Nasdaq: LIOX ) ... new, three-year master services agreement with a ... services that serve patients in approximately 100 ... the sole provider for translation of the ... training, human resources, legal, and corporate communications ...
Breaking Biology Technology:AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3
... Cardium Therapeutics,(Amex: CXM ) and its ... has entered into a exclusive commercialization agreement ... of medical products.,N.G.C. Medical primarily sells medical ... cardiology markets. They also provide,in-service management of ...
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that ... will,provide a corporate update at the upcoming Jefferies 2nd ... 26, 2008 at the Mandarin,Oriental in New York, NY., ... presentation by visiting,the Sunesis website at http://ir.sunesis.com . ...
... grow at CAGRs of nearly, 60% and 20%, respectively, through 2012, according ... ... WALTHAM, Mass., June 19 According to Millennium,Research Group,s Japanese Markets ... increase at a compound annual,growth rate (CAGR) of nearly 60% through 2012 ...
Other Biology Technology:Cardium's InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems 2Cardium's InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems 3Cardium's InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems 4Cardium's InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems 5Cardium's InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems 6Aortic Stent Grafts Will Boost Canadian and Japanese Peripheral Vascular Markets 2
(Date:12/14/2009)... a defining feature of humans. That,s until examples of tool ... an array of other mammals. Now, a report in the ... Press publication, adds an octopus to the growing list of ... behavioral trick that the researchers call stilt walking. In it, ... "bowls," makes its eight arms rigid, and raises the whole ...
(Date:12/13/2009)... may help to engineer plants that take advantage of ... finding could help to engineer crops that take advantage ... carbon dioxide they need for photosynthesis through microscopic breathing ... molecule of the gas gained, they lose hundreds of ... tighten to save water when CO 2 is ...
(Date:12/13/2009)... CADecember 10, 2009Researchers at The Scripps Research Institute ... single protein from an ancient family of enzymes ... body. In addition to providing guidance for understanding ... a theoretical underpinning for the protein,s possible use ... , The research was published in the December ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3SAFC Supply Solutions 28R 29 Announces Raw Materials Line Developed Specifically to Meet Molecular Diagnostics Manufacturing Requirements 13111 1SAFC Supply Solutions 28R 29 Announces Raw Materials Line Developed Specifically to Meet Molecular Diagnostics Manufacturing Requirements 13111 2SAFC Supply Solutions 28R 29 Announces Raw Materials Line Developed Specifically to Meet Molecular Diagnostics Manufacturing Requirements 13111 3Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol 52172 1Can the relationship between doctors and drug companies ever be a healthy one 3F 52168 1Can the relationship between doctors and drug companies ever be a healthy one 3F 52168 2
... common antipsychotic drug used in emergency rooms to treat ... the brain known to regulate movement, a new study ... indicate that only the combination of the medication, haloperidol, ... alone. Senior author Bryan Yamamoto, PhD, and his team ...
... watershed decision to propose listing the polar bear as ... Society (WCS) is launching a bold initiative to save ... bears themselves, but the receding sea ice habitat that ... In a project named "Warm Waters for Cool Bears," ...
... meaning to watching out for other mothers' kids. , ... by the University of Alberta in Edmonton, Canada and the ... responded to the recorded distress calls of fawns, similar to ... mothers responding to both whitetail and mule deer calls, even ...
Other Biology News:Common treatment for methamphetamine overdose may damage brain cells 2Want to save polar bears? Follow the ice 2Want to save polar bears? Follow the ice 3Mule deer moms rescue other fawns 2
Human ULBP-3 MAb (Clone 166514)...
Homo sapiens CDC23 (cell division cycle 23, yeast, homolog),...
Homo sapiens postsynaptic protein CRIPT Antigen: Recombinant Protein...
Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: